Fisher & Paykel Healthcare Corporation Limited provided revenue and net profit after tax guidance for the first half of the 2023 financial year ending 30 September 2022. At current exchange rates, and assuming a continuation of trading conditions in the first four months, the company expects operating revenue for the first half of the 2023 financial year to be approximately $670 million and net profit after tax to be approximately $85 million to $95 million. This would represent an increase in revenue on pre-pandemic levels (first half of fiscal year 2020: $570.9 million) and a decline in revenue compared to the prior comparable period (first half of fiscal year 2022: $900.0 million).
Fisher & Paykel Healthcare Corporation Limited
Equities
FPH
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.55 NZD | +1.57% | +4.20% | +20.97% |
09/04 | New Zealand Shares Fall for Second Day; Fisher & Paykel Healthcare Launches Apnea Mask | MT |
09/04 | Fisher & Paykel Begins Selling Lightest Mask for Sleep Apnea | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.97% | 10.03B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.66% | 26.59B | |
+3.21% | 26.78B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- FPH Stock
- News Fisher & Paykel Healthcare Corporation Limited
- Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of Fiscal Year 2023